Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: a registry-based analysis.
暂无分享,去创建一个
A. Poprach | B. Melichar | L. Dušek | Z. Bortlíček | R. Vyzula | T. Buchler | O. Fiala | I. Kiss | M. Zemanova | K. Kubáčková